Genmab AS (GMAB) — Cash Flow Reinvestment Rate
Genmab AS (GMAB) has a Cash Flow Reinvestment Rate of 5.56x as of December 2025, reinvesting $1.67 Billion (capex $12.99 Million plus investments $1.66 Billion) from operating cash flow of $300.34 Million. See cash generation quality of Genmab AS to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Genmab AS Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Genmab AS across 15 annual periods. For the full cash flow conversion analysis, see Genmab AS (GMAB) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Genmab AS (2007–2025)
Year-by-year capital reinvestment analysis for Genmab AS. See Genmab AS financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.40x | $1.66 Billion | $1.19 Billion | $37.03 Million | ▲ +7.9% |
| 2024 | 1.30x | $10.09 Billion | $7.77 Billion | $187.00 Million | ▲ +609.0% |
| 2023 | 0.18x | $1.35 Billion | $7.38 Billion | $376.00 Million | ▼ -76.7% |
| 2022 | 0.79x | $3.08 Billion | $3.91 Billion | $317.00 Million | ▲ +82.4% |
| 2021 | 0.43x | $961.00 Million | $2.23 Billion | $252.00 Million | ▲ +4.4% |
| 2020 | 0.41x | $2.66 Billion | $6.43 Billion | $307.00 Million | ▼ -73.8% |
| 2019 | 1.58x | $2.09 Billion | $1.33 Billion | $111.00 Million | ▼ -28.9% |
| 2018 | 2.22x | $2.25 Billion | $1.01 Billion | $477.37 Million | ▲ +367.0% |
| 2017 | 0.48x | $756.08 Million | $1.59 Billion | $88.51 Million | ▼ -85.1% |
| 2016 | 3.20x | $1.05 Billion | $327.72 Million | $33.11 Million | ▲ +629.7% |
| 2015 | 0.44x | $136.45 Million | $311.45 Million | $135.39 Million | ▼ -23.0% |
| 2014 | 0.57x | $75.44 Million | $132.67 Million | $75.44 Million | ▲ +348.2% |
| 2012 | 0.13x | $9.00 Million | $70.92 Million | $9.00 Million | ▲ +236.5% |
| 2010 | 0.04x | $10.11 Million | $268.17 Million | $10.11 Million | ▲ +48.5% |
| 2007 | 0.03x | $12.84 Million | $505.90 Million | $12.84 Million | — |